3–12 day dispatch window due to updated U.S. documentation requirements • All tariff costs covered
Showing all 2 results
Botulax is a botulinum toxin type A injectable manufactured in South Korea by Hugel Pharma, designed to temporarily relax facial muscles and treat a range of medical conditions. Whether you’re a practitioner selecting the right formulation for cosmetic dermatology or therapeutic applications, this guide breaks down the available Botulax vial sizes, what to look for in each product, and how to choose the right option for your patients seeking optimal results.
BOTULAX® is available in 50, 100, and 200 unit vials, with Botulax 300 Units also available for purchase online. Each concentration serves a distinct purpose depending on the treatment area, patient profile, and clinical goals.
Botulax 100U is the most widely referenced formulation for focused cosmetic treatments – ideal for addressing glabellar lines, crow’s feet, and forehead lines in adult patients. Botulax contains 844 ± 43 pg of toxin per 100 U vial, reflecting its 900 kDa complex composition with human serum albumin and sodium chloride as excipients. This is the go-to unit size for practitioners handling single-area wrinkle reduction or patients new to botulinum toxin treatments.
The 200 units vial suits practices treating multiple facial zones in a single session – combining areas like the forehead, glabella, and crow’s feet, or addressing platysmal bands alongside procerus muscle activity. For clinics with moderate patient volume, this size reduces waste and lowers cost per unit compared to opening multiple 100U vials.
Designed for large treatment areas and therapeutic settings, the 300U vial is the professional-grade option for experienced medical professionals managing muscle spasticity, hyperhidrosis, or high-volume aesthetic practices. In clinical studies on post-stroke upper limb spasticity, mean Botulax doses of approximately 309 U were administered across multiple muscles – making this vial size practical for such therapeutic applications without requiring multiple smaller vials.
Selecting the right botulinum toxin product comes down to three concrete attributes: purity, onset and duration, and storage integrity. Each directly affects patient satisfaction and treatment consistency.
Botulax uses the clostridium botulinum toxin type A in its 900 kDa molecular complex form, meaning the neurotoxin is accompanied by accessory proteins (hemagglutinins and non-hemagglutinins). While this is standard among many botulinum toxin brands, it distinguishes Botulax from purified core-only (150 kDa) formulations like incobotulinumtoxin A, which strip away complexing proteins to potentially reduce immunogenic risk. Hugel Pharma manufactures Botulax under strict quality control – Botulax is FDA approved and trusted in over 67 countries. For context, Botulax contains 844 ± 43 pg of toxin per 100 U vial, while Nabota contains 754 ± 11 pg of toxin per 100 U vial, illustrating that protein load varies across other botulinum toxin brands.
Initial effects of Botulax appear within 2 to 4 days, with full results visible in 1 to 2 weeks. The effects of Botulax typically last 3 to 6 months – results for dynamic facial wrinkles can last up to 6 months, while Botulax effects typically last 3–4 months after treatment in many clinical scenarios. Nabota may last around 3–4 months, similar to Botulax. Botulax effects may vary based on dosage, treatment area, and individual patient characteristics. In therapeutic trials such as the cerebral palsy study, efficacy evaluations extended up to 24 weeks, demonstrating sustained clinical benefit in higher-dose applications. Survey data from Korean dermatologists indicates retreatment intervals of approximately six months for cosmetic indications, with a common dilution of 100 U per 2.5 mL saline for wrinkle treatments.
Like all botulinum toxin products, Botulax requires proper cold-chain storage at 2–8°C to maintain potency and shelf life. Deviations in temperature can lead to degradation that reduces efficacy without necessarily affecting safety. The reconstituted product should be used promptly per manufacturer guidelines. Always verify the manufacturing date, batch numbers, and cold-chain integrity upon delivery – this is especially important when purchasing from distributors offering fast shipping, as transit conditions directly affect the reliability of the formulation.
Selecting the right Botulax formulation depends on a few practical criteria that narrow the decision quickly:
Botulax offers a reliable, clinically validated botulinum toxin product across multiple vial sizes to match specific patient needs – from targeted cosmetic procedures to large-area therapeutic applications. Botulax is a brand of botulinum toxin type A injectable with comparable efficacy to leading brands, backed by randomized controlled trials and trusted in over 67 countries. For informed decision making, consult with qualified medical professionals who can assess your treatment goals and recommend the appropriate formulation, dosage, and approach for the best patient satisfaction. For further assistance in purchasing or selecting the right solution, explore our range or reach out to our team.
You may download the form, complete it and email back to [email protected].
Or fax it at 360.768.3126